New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT

Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are twenty-five… The post New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: